NCT00005802View on ClinicalTrials.gov

Chemotherapy Followed by Donor White Blood Cells Plus Interleukin-2 in Treating Patients With Acute Myeloid or Lymphocytic Leukemia

PHASE1/PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

June 30, 1999

Primary Completion Date

March 31, 2005

Study Completion Date

March 31, 2005

Conditions
Leukemia
Interventions
BIOLOGICAL

aldesleukin

BIOLOGICAL

filgrastim

BIOLOGICAL

therapeutic allogeneic lymphocytes

DRUG

cytarabine

DRUG

etoposide

DRUG

fludarabine phosphate

DRUG

methotrexate

DRUG

mitoxantrone hydrochloride

DRUG

therapeutic hydrocortisone

RADIATION

radiation therapy

Trial Locations (1)

98109-1024

Fred Hutchinson Cancer Research Center, Seattle

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Fred Hutchinson Cancer Center

OTHER

NCT00005802 - Chemotherapy Followed by Donor White Blood Cells Plus Interleukin-2 in Treating Patients With Acute Myeloid or Lymphocytic Leukemia | Biotech Hunter | Biotech Hunter